Pharmacy News

APhA2021: Federal Pharmacy Forum brought forces together

The 21st Annual APhA Federal Pharmacy Forum’s opening ceremony and education sessions were held Friday, March 12, in conjunction with APhA2021 Virtual. Approximately 85 pharmacists and pharmacy technicians attended from the U.S. Army (USA), Navy (USN), Air Force (USAF), Coast Guard (USCG), Public Health Service (USPHS), Department of Veterans Affairs (VA), and the Defense Health Agency (DHA). Student pharmacists and others also attended, and approximately 14 supporting industry partners exhibited.

House passes $1.9 trillion COVID-19 stimulus bill; Biden to sign Friday

President Biden is expected Friday to sign legislation that will provide $1.9 trillion in COVID-19 relief. The bill allocates $7.5 billion for vaccine distribution initiatives and $48 billion for testing and contact tracing, with billions more going toward child care, rental assistance, and more.

CDC says fully vaccinated people can gather privately without masks

CDC has updated its guidance regarding Americans who are fully immunized against coronavirus, meaning it has been at least 2 weeks since they received their second dose of the Pfizer and Moderna vaccines or their only dose of the Johnson & Johnson vaccine.

Consistent education, use of opioid-sparing regimens can reduce misuse among kids having surgery

After a comprehensive literature review, the American Pediatric Surgical Association (APSA) Outcomes and Evidence-Based Practice Committee, along with a panel of health care and opioid stewardship leaders, issued 20 recommendations on perioperative use of opioids in children ages 18 years and younger. In November 2020, JAMA Surgery published the recommendations, which include pre- and postsurgery opioid education for patients and families, limited use of tramadol and codeine in children, and use of nonopioid analgesics for certain procedures.

U.S. government scientists skeptical of one-shot regimen for Pfizer, Moderna COVID vaccines

U.S. health experts say they cannot get behind proposals to switch to single-dose regimens of the Pfizer and Moderna coronavirus vaccines, which were approved under a two-dose protocol. Seven U.S.